Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
暂无分享，去创建一个
Sung-Bae Kim | C. Swanton | S. Johnston | R. Schmid | K. Guiver | W. Arpornwirat | I. Chitapanarux | V. Ganju | S. Im | A. Dechaphunkul | J. Maneechavakajorn | N. Spector | T. Yau | M. Afrit | S. Ahmed | N. Gibson | M. Uttenreuther-Fischer | Javier Herrero | Gerald Goh